Misplaced Pages

Furafylline

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.

This is an old revision of this page, as edited by CheMoBot (talk | contribs) at 20:04, 12 July 2011 (Updating {{drugbox}} (no changed fields - added verified revid - updated 'UNII_Ref', 'ChemSpiderID_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEMBL_Ref', 'KEGG_Ref') per Chem/Drugbox validation (). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Revision as of 20:04, 12 July 2011 by CheMoBot (talk | contribs) (Updating {{drugbox}} (no changed fields - added verified revid - updated 'UNII_Ref', 'ChemSpiderID_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEMBL_Ref', 'KEGG_Ref') per Chem/Drugbox validation ()(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) Pharmaceutical compound
Furafylline
Identifiers
IUPAC name
  • 3-(furan-2-ylmethyl)-1,8-dimethyl-7H-purine-2,6-dione
CAS Number
PubChem CID
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC12H12N4O3
Molar mass60.25 g/mol
  (verify)

Furafylline is a methylxanthine derivative that was introduced in hope of being a long-acting replacement for theophylline in the treatment of asthma. It is an inhibitor of CYP1A2.

References

  1. ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 2378786, please use {{cite journal}} with |pmid= 2378786 instead.
Stub icon

This pharmacology-related article is a stub. You can help Misplaced Pages by expanding it.

Categories: